Which among the following is the MOST effective antitubercular drug against slow multiplying intracellular mycobacteria?
**Core Concept**
The question is testing the understanding of the pharmacodynamics and pharmacokinetics of antitubercular drugs, particularly their effectiveness against slow multiplying intracellular mycobacteria. **Isoniazid (INH)**, **Rifampicin (RMP)**, **Ethambutol (EMB)**, and **Pyrazinamide (PZA)** are the mainstay antitubercular drugs, each with unique mechanisms of action and efficacy profiles.
**Why the Correct Answer is Right**
Isoniazid is the most effective antitubercular drug against slow multiplying intracellular mycobacteria. It acts by inhibiting the synthesis of mycolic acid, a critical component of the mycobacterial cell wall, through the inhibition of the enzyme enoyl-ACP reductase (InhA). This action is particularly effective against slow multiplying intracellular mycobacteria, such as those found in the acidic environment of the phagolysosome.
**Why Each Wrong Option is Incorrect**
* **Option A:** Rifampicin is a potent bactericidal agent against rapidly multiplying extracellular mycobacteria, but it is less effective against slow multiplying intracellular mycobacteria.
* **Option B:** Ethambutol inhibits the synthesis of arabinogalactan, a component of the mycobacterial cell wall, but it is not as effective as isoniazid against slow multiplying intracellular mycobacteria.
* **Option D:** Pyrazinamide is effective against dormant mycobacteria in the acidic environment of the phagolysosome, but it is not as potent as isoniazid against slow multiplying intracellular mycobacteria.
**Clinical Pearl / High-Yield Fact**
Isoniazid is most effective against slow multiplying intracellular mycobacteria, particularly in the acidic environment of the phagolysosome. This is due to its ability to penetrate and accumulate within the mycobacterial cell, where it can effectively inhibit the synthesis of mycolic acid.
**Correct Answer:** C. Isoniazid.